The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain medicines. View on euronews ...